The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
BIOVENTUS | COM CL A | 09075A108 | 42,970,369 | 13,021,324 | SH | SOLE | 13,021,324 | 0 | 0 | |||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 27,892,459 | 3,490,921 | SH | SOLE | 3,490,921 | 0 | 0 | |||
MEDICINOVA INC | COM NEW | 58468P206 | 2,311,417 | 1,105,941 | SH | SOLE | 1,105,941 | 0 | 0 | |||
REVANCE THERAPEUTICS INC | COM | 761330109 | 5,242,765 | 457,085 | SH | SOLE | 457,085 | 0 | 0 | |||
TELA BIO, INC. | COM | 872381108 | 32,885,672 | 4,110,709 | SH | SOLE | 4,110,709 | 0 | 0 | |||
VENUS CONCEPT, INC. | COM | 92332W105 | 2,134,822 | 1,089,195 | SH | SOLE | 1,089,195 | 0 | 0 |